SOME ASPECTS OF THE COMPLEX TREATMENT OF WOMEN OF REPRODUCTIVE AGE WITH CERVICAL ECTOPY ASSOCIATED WITH HUMAN PAPILLOMAVIRUS
DOI:
https://doi.org/10.11603/24116-4944.2018.2.9131Keywords:
human papillomavirus, cervical ectopy, tilorone; inosin, complex treatmentAbstract
The aim of the study – on the basis of the analysis of data from literary sources and materials of own observations, to compare the efficiency and safety of the use of Tirolon and Inosin Pranobex drugs in the complex treatment and prevention of relapse in women of reproductive age with ectopic cervix on the background of a papillomavirus infection of high-risk oncogenic (types 16, 18, 31, 33), as well as study immune and hormonal changes in the specified pathology.
Materials and Methods. During the five years (2012–2017) before and after the complex treatment, both 87 patients aged 18 to 35 years old were examined using both conventional and special diagnostic methods with an ectopic examination of the cervical epithelium of the cervix associated with high-risk papillomavirus infection oncogenic risk. Polymerase chain reaction studies were performed using test systems for the amplification of homologous DNA fragments of a human papillomavirus virus of high-oncogenic risk (types 16, 18, 31, 33). Extended colposcopy was performed by the colposcope MK – 200. A cytological and immunological study was conducted, blood concentrations of gonadotropic and steroid hormones were studied. To evaluate the biocenosis of the vagina, selective differential diagnostic nutrient media were used by determining the species and number of microorganisms of vaginal contents according to generally accepted methods.
Results and Discussion. The average age of women was (26.5±2.7) years, the average duration of the disease (3.8±2.1) years and probably did not differ between the established clinical groups. During the extended colposcopy, after the end of treatment, 20 (68.97 %) patients of the I (main), 19 (65.52 %) – ІІ (main) and 17 (58.62 %) – of ІІІ (control) groups were noted, the absence of the ectopic of the neck uterus. Laboratory data after treatment demonstrated a normalization of estradiol and progesterone levels in 29 (100 %) patients in the I (main) group. In II (main) group normalization of gonadotropic hormones was observed in all 29 (100 %) patients; Normal parameters of estradiol were recorded in 9 (31.03 %) patients, and progesterone in 7 (24.14 %). After the performed immunotherapy, it was possible to achieve elimination of human papillomavirus in 24 (82.76 %) patients of the I (main) and 23 (79.31 %) of women of the II (main) group.
Conclusion. The results of the study were obtained (in 82.76 % of patients in group I and 79.31 % of the II clinical groups, the elimination of the human papillomavirus was confirmed by polymerase chain reaction tests, good tolerance and no side effects), and the literature data indicate a high clinical efficacy of active reagent drugs which are tiloron and inosin in the scheme of integrated treatment of women of fertile age with ectopic cervix associated with papillomavirus infection.
References
Bitkina, O.A., & Ovsyannikova, R.D. (2004). Zabolevaniya, vyzyvayemyye virusom papillomy cheloveka [Diseases caused by human papillomavirus]. Moscow: Med. kniga [in Russian].
Vovk, I.B., Kondratyuk, V.K., Yunger, V.I., & Kalyuta, A.A. (2009). Genferon v kompleksnom lechenii fonovykh protsessov sheyki matki u patsiyentok s vospalitelnymi zabolevaniyami genitaliy [Genferon in complex treatment of background processes of the cervix in patients with inflammatory diseases of the genitals]. Zdorovye zhenshchiny – Women’s Health, 8 (44), 40-45 [in Russian].
Kedrova, A.G., Podiyetov, Yu.I., Kuznetsov, V.V., & Bryuzhin, V.V. (2006). Rol protivovirusnoy terapii v kompleksnom lechenii bolnykh epitelialnymi displaziyami i preinvazivnym rakom sheyki matki [The role of antiviral therapy in the complex treatment of patients with epithelial dysplasia and preinvasive cervical cancer]. Akusherstvo i ginekologiya – Obstetrics and Gynecology, 6, 27-30 [in Russian].
Kulakov, V.I., Paavonen, Y., & Prilepskaya, V.N. (2008). Profilaktika raka sheyki matki: Rukovodstvo dlya vrachey [Prevention of cervical cancer: A guide for doctors]. Moscow [in Russian].
Kiselev, V.I. (2004). Virusy papillomy cheloveka v razvitii raka sheyki matki [Human papillomaviruses in the development of cervical cancer]. Moscow: Kompaniya “Dimitreyd Grafik Grupp” [in Russian].
Minkina, G.N., & Rusakevich, P.S. (2000). Zabolevaniya sheyki matki [Diseases of the cervix]. Minsk [in Russian].
Podolskiy, V.V., Shkiryak-Nizhnik, Z.A., & Gorovenko, N.G. (2003). O neobkhodimosti kompyuternoy bazy dannykh dlya opredeleniya sostoyaniya reproduktivnogo zdorovya zhenshchin fertilnogo vozrasta [On the need for a computer database for determining the status of reproductive health in fertile-age women]. Zdorovye zhenshchiny – Women’s Health, 2 (14), 76-81 [in Russian].
Prilepskaya, V.N. (2008). Patologiya sheyki matki i genitalnyye infektsii [Pathology of the cervix and genital infections]. Moscow: MED press-inform [in Russian].
Shvarts, T.Ya., Prilepskaya, V.P., & Mynbayev, O.A. (2011). Izoprinozin v lechenii papillomavirusnoy infektsii v ginekologicheskoy praktike [Isoprinosine in the treatment of papillomavirus infection in gynecological practice]. Moscow [in Russian].
Dovlethanova, E.R., & Prilepskaya, V.N. (2015). A differentiated approach to the treatment of genital disease in women associated with HPV infection. Obstetrics and Gynecology, 10, 118-124.
Gillet, E., Meys, J.F., Verstraelen, H., Bosire, C., De Sutter, P., Temmerman, M., & Broeck, D.V. (2011). Bacterial vaginosis is associated with urerine cervical human papillomavirus infection: a meta-analysis. BMC Infect. Dis., 11, 10-11.
Hryanin, A.A., & Reshetnikov, O.V. (2015). Inductors interferon in the treatment of genital herpes in women. Obstetrics and Gynecology, 7, 88-89.
Mayrand, M.H., Duarte-Franco, E., Rodrigues, I., Walter, S.D., Hanley, J., & Ferenczy, A. (2007). Human papillomavirus DNA versus Papanicolaou screening tests cervical. Retrieved from: https://www.nejm.org/doi/full/10.1056/nejmoa071430.
Prilepskaya, V.N., Nazarova, N.M., Mzarelua, G.M., Fazullin, L.Z., & Trofimova, D.Yu. (2015). HPV-associated cervical disease – new in diagnostics. Obstetrics and Gynecology, 8, 20-26.
Roman, A., & Munger, K. (2013). The papillomavirus E7 proteins. Virology, 445 (1-2), 138-168.
Sadler, L., Saftlas, A., Wang, W., Exeter, M., Whittaker, J., & McCowan, L. (2004). Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA, 291, 2100-2106.
Wang, X., Wang, H-K., & Proc, Y.Li. (2014). Micro RNAs are biomarkers of oncogenic human papillomavirus infections. Natl. Acad. Sci. USA, 111 (11), 4262-4267.
Downloads
Published
Issue
Section
License
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
